+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Corticosteroids Therapy Market by Route Of Administration (Inhalation, Injectable, Oral), Indication (Allergic Rhinitis, Asthma, Dermatological Disorders), Drug Type, Dosage Form, Patient Age Group - Global Forecast 2025-2030- Product Image
Corticosteroids Therapy Market by Route Of Administration (Inhalation, Injectable, Oral), Indication (Allergic Rhinitis, Asthma, Dermatological Disorders), Drug Type, Dosage Form, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Corticosteroids Therapy Market by Route Of Administration (Inhalation, Injectable, Oral), Indication (Allergic Rhinitis, Asthma, Dermatological Disorders), Drug Type, Dosage Form, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888287
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Corticosteroids Therapy Market is undergoing significant transformation, driven by ongoing innovation in drug formulations, evolving regulatory pathways, and the adoption of digital health solutions. Senior stakeholders are poised to benefit from these advancements as they evaluate emerging opportunities, regulatory challenges, and critical strategic developments shaping future growth across global markets.

Market Snapshot: Corticosteroids Therapy Market Size and Growth

The corticosteroids therapy market grew from USD 5.26 billion in 2024 to USD 5.69 billion in 2025. Demonstrating a robust CAGR of 7.79%, the market is projected to reach USD 8.25 billion by 2030. This momentum is fueled by advancements in formulation science, the integration of connected health technologies, and a shift toward precision medicine principles. The market’s evolution is characterized by changing patient access models, regulatory innovations, and heightened emphasis on safety and efficacy standards. Regional adaptation remains important as supply chains and commercial strategies must respond rapidly to clinical, policy, and technology shifts.

Scope & Segmentation

Market Segments Overview

  • Route of Administration: Inhalation (dry powder inhaler, metered dose inhaler, nebulizer), injectable (intramuscular, intravenous, subcutaneous), oral (suspension, tablet), topical (cream, lotion, ointment).
  • Therapeutic Indications: Applications for allergic rhinitis, asthma, dermatological disorders, inflammatory bowel disease, and rheumatoid arthritis.
  • Drug Types: Budesonide, dexamethasone, hydrocortisone, methylprednisolone, prednisone.
  • Dosage Formulations: Cream, injection, suspension, tablet.
  • Patient Age Groups: Adult, geriatric, pediatric.

Geographic Coverage

  • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina.
  • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland.
  • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.

Industry Players & Technologies

  • Key Companies: GlaxoSmithKline plc, AstraZeneca plc, Novartis AG, Sanofi S.A., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Sandoz International GmbH.
  • Technologies: Advanced inhalation devices, sustained-release injectables, digital health platforms for adherence tracking, connected telehealth solutions, and eco-conscious packaging.

Key Takeaways for Decision-Makers

  • The market features increased collaboration among manufacturers, clinicians, and policymakers to enhance therapeutic safety, efficacy, and patient-centric care models.
  • Innovation in drug delivery—such as precision inhalation and sustained-release formulations—improves adherence and expands the spectrum of treatable indications.
  • Flexible regulatory approval pathways and harmonization initiatives accelerate time-to-market for new therapies while supporting global clinical development strategies.
  • Digital health integration empowers real-time adherence monitoring and personalized dosing, supporting both clinical outcomes and commercial differentiation.
  • Patient-age specific dosage forms and targeted marketing are gaining relevance, with innovation particularly focused on pediatric and geriatric compliance challenges.
  • Sustainability in packaging and supply chain transparency are increasingly important for corporate reputation and operational risk management.

Tariff Impact: Navigating Supply Chain and Policy Shifts

Recent changes in United States tariff schedules affecting pharmaceutical ingredients and finished corticosteroid products have introduced new complexities for global manufacturers. These adjustments have elevated input costs, triggered sourcing diversifications, and prompted companies to invest in advanced analytics for real-time supply chain management. Emerging economies have been impacted by distribution interruptions, underlining the necessity of transparent cross-border partnerships and active policy scenario planning. Robust tariff sensitivity analysis and regional production planning are now core components of operational resilience strategies in this sector.

Methodology & Data Sources

This report employs a robust, multi-stage methodology combining comprehensive secondary research, in-depth interviews with industry experts, and primary data from key market participants. Triangulation ensures consistency across quantitative and qualitative findings, while peer review and expert validation safeguard accuracy and reliability from study conception to final insights.

Why This Report Matters

  • Provides actionable insights for executives aiming to optimize portfolio strategies and navigate evolving regulatory and supply chain environments.
  • Enables precise identification of emerging opportunities, from segmentation innovation to geographic expansion and digital health integration, supporting informed commercial and investment decisions.
  • Delivers a comprehensive overview of market drivers, stakeholder dynamics, and risk mitigation strategies essential for sustaining competitive advantage in a dynamic global landscape.

Conclusion

Leaders equipped with specialized insights from this market research are well-positioned to capitalize on significant growth opportunities within corticosteroids therapy. Ongoing innovation, digital adoption, and proactive supply chain strategies will help shape competitive leadership and lasting value in this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Impact of targeted inhaled corticosteroid formulations on severe asthma management costs and outcomes
5.2. Emerging small-molecule glucocorticoid receptor modulators aiming to reduce systemic side effects in chronic inflammatory diseases
5.3. Expansion of biosimilar corticosteroid injectables improving access in emerging markets and driving price competition
5.4. Development of nanotechnology-based corticosteroid drug delivery systems for enhanced ocular and dermal therapy efficacy
5.5. Integration of digital health platforms for remote monitoring of biologic corticosteroid therapy adherence in rheumatoid arthritis
5.6. Growing adoption of combination corticosteroid and immunomodulator therapies for atopic dermatitis with improved patient adherence
5.7. Regulatory changes accelerating approval pathways for novel inhaled corticosteroid therapies targeting pediatric asthma populations
5.8. Advancements in gene expression profiling guiding personalized dosing strategies for systemic corticosteroid regimens in autoimmune conditions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Corticosteroids Therapy Market, by Route Of Administration
8.1. Introduction
8.2. Inhalation
8.2.1. Dry Powder Inhaler
8.2.2. Metered Dose Inhaler
8.2.3. Nebulizer
8.3. Injectable
8.3.1. Intramuscular
8.3.2. Intravenous
8.3.3. Subcutaneous
8.4. Oral
8.4.1. Suspension
8.4.2. Tablet
8.5. Topical
8.5.1. Cream
8.5.2. Lotion
8.5.3. Ointment
9. Corticosteroids Therapy Market, by Indication
9.1. Introduction
9.2. Allergic Rhinitis
9.3. Asthma
9.4. Dermatological Disorders
9.5. Inflammatory Bowel Disease
9.6. Rheumatoid Arthritis
10. Corticosteroids Therapy Market, by Drug Type
10.1. Introduction
10.2. Budesonide
10.3. Dexamethasone
10.4. Hydrocortisone
10.5. Methylprednisolone
10.6. Prednisone
11. Corticosteroids Therapy Market, by Dosage Form
11.1. Introduction
11.2. Cream
11.3. Injection
11.4. Suspension
11.5. Tablet
12. Corticosteroids Therapy Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Corticosteroids Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Corticosteroids Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Corticosteroids Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. AstraZeneca plc
16.3.3. Novartis AG
16.3.4. Sanofi S.A.
16.3.5. Merck & Co., Inc.
16.3.6. Pfizer Inc.
16.3.7. Teva Pharmaceutical Industries Ltd
16.3.8. Sun Pharmaceutical Industries Ltd
16.3.9. Mylan N.V.
16.3.10. Sandoz International GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CORTICOSTEROIDS THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CORTICOSTEROIDS THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CORTICOSTEROIDS THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CORTICOSTEROIDS THERAPY MARKET: RESEARCHAI
FIGURE 26. CORTICOSTEROIDS THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 27. CORTICOSTEROIDS THERAPY MARKET: RESEARCHCONTACTS
FIGURE 28. CORTICOSTEROIDS THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CORTICOSTEROIDS THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY LOTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY LOTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY BUDESONIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY BUDESONIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PREDNISONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 136. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 137. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 138. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 139. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 140. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 141. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 241. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 244. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 245. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 248. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 250. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 251. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 262. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 263. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 266. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 267. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 268. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 269. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 298. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 299. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 300. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 301. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 302. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 303. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 304. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 305. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 310. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 311. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 312. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 313. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 314. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 315. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 316. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 317. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 320. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 321. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 322. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 323. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 326. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 327. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 328. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 329. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 330. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRAT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Corticosteroids Therapy market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Novartis AG
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan N.V.
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.25 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Adrenal Corticosteroid Inhibitors Market by Route Of Administration (Injectable, Oral, Topical), Mechanism Of Action (Non Selective Inhibitors, Selective 11ß-Hsd1 Inhibitors), Application, Distribution Channel, Molecule Type, End User - Global Forecast 2025-2030 - Product Image

Adrenal Corticosteroid Inhibitors Market by Route Of Administration (Injectable, Oral, Topical), Mechanism Of Action (Non Selective Inhibitors, Selective 11ß-Hsd1 Inhibitors), Application, Distribution Channel, Molecule Type, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Corticosteroids Inhalation Formulation Market by End User, Indication, Distribution Channel, Dosage Form, Molecule - Global Forecast to 2030 - Product Image

Corticosteroids Inhalation Formulation Market by End User, Indication, Distribution Channel, Dosage Form, Molecule - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Corticosteroids Therapy - Global Strategic Business Report - Product Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Nasal Corticosteroids - Global Strategic Business Report - Product Image

Nasal Corticosteroids - Global Strategic Business Report

  • Report
  • 469 Pages
  • Global
From

About the Corticosteroid Market

The Corticosteroid market is a segment of the Healthcare Services industry that focuses on the production and distribution of corticosteroid drugs. Corticosteroids are a class of drugs used to treat a variety of conditions, including allergies, asthma, and autoimmune diseases. They are also used to reduce inflammation and swelling. Corticosteroids are available in both oral and injectable forms, and are often prescribed in combination with other medications. The Corticosteroid market is highly competitive, with a number of large pharmaceutical companies producing and distributing these drugs. Companies in the market are focused on developing new formulations and delivery systems to improve patient outcomes. They are also investing in research and development to create new treatments for a variety of conditions. Some of the major companies in the Corticosteroid market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are involved in the production, distribution, and marketing of corticosteroid drugs. They are also involved in research and development to create new treatments and formulations. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.